These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2959963)

  • 1. Beneficial effects of thromboxane receptor antagonists in acute cardiovascular crises.
    Lefer AM
    Prog Clin Biol Res; 1987; 242():221-8. PubMed ID: 2959963
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology of thromboxane A2 receptor antagonists.
    Halushka PV
    Z Kardiol; 1989; 78 Suppl 3():42-7. PubMed ID: 2530712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of thromboxane receptor antagonists in cardiovascular disease.
    Smith EF
    Prog Clin Biol Res; 1989; 301():29-38. PubMed ID: 2529549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial actions of the thromboxane receptor antagonist, AH-23,848, in acute myocardial ischemia.
    Brezinski ME; Osborne JA; Yanagisawa A; Lefer AM
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):703-9. PubMed ID: 2966270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboxane synthetase inhibitors, thromboxane receptor antagonists, and aspirin in cardiovascular disease.
    Dorn GW; Halushka PV
    Ration Drug Ther; 1985 Jul; 19(7):1-7. PubMed ID: 2997839
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular and functional evidence for the distinct nature of F2-isoprostane receptors from those of thromboxane A2.
    Yura T; Fukunaga M; Grygorczyk R; Makita N; Takahashi K; Badr KF
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():237-9. PubMed ID: 7732843
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumour cell proliferation by thromboxane A2: a receptor-mediated event.
    Nigam S; Zakrzewicz A
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():925-8. PubMed ID: 1705088
    [No Abstract]   [Full Text] [Related]  

  • 8. Thromboxane and prostacyclin receptors.
    Halushka PV; Mais DE; Morinelli TA
    Prog Clin Biol Res; 1989; 301():21-8. PubMed ID: 2529548
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostaglandin endoperoxide and thromboxane A2 analogs.
    Wilson NH; Jones RL
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 14():393-425. PubMed ID: 2992245
    [No Abstract]   [Full Text] [Related]  

  • 10. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
    [No Abstract]   [Full Text] [Related]  

  • 11. Azulene derivatives: new non-prostanoid thromboxane A2 receptor antagonists.
    Tomiyama T; Wakabayashi S; Kosakai K; Yokota M
    J Med Chem; 1990 Sep; 33(9):2323-6. PubMed ID: 2144025
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostaglandin receptors in the cardiovascular system: potential selectivity from receptor subtypes or modified responsiveness.
    Keen M; Kelly E; MacDermot J
    Eicosanoids; 1989; 2(4):193-7. PubMed ID: 2698224
    [No Abstract]   [Full Text] [Related]  

  • 13. Thromboxanes as mediators of cardiovascular disease states.
    Lefer AM; Smith JB
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():473-5. PubMed ID: 2936146
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades.
    Jones DA; Benjamin CW; Linseman DA
    Mol Pharmacol; 1995 Nov; 48(5):890-6. PubMed ID: 7476920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
    Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
    J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of prostacyclin in the cardiovascular response to thromboxane A2.
    Cheng Y; Austin SC; Rocca B; Koller BH; Coffman TM; Grosser T; Lawson JA; FitzGerald GA
    Science; 2002 Apr; 296(5567):539-41. PubMed ID: 11964481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
    Mais DE; Saussy DL; Chaikhouni A; Kochel PJ; Knapp DR; Hamanaka N; Halushka PV
    J Pharmacol Exp Ther; 1985 May; 233(2):418-24. PubMed ID: 2987481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostanoid receptors and their biological actions.
    Negishi M; Sugimoto Y; Ichikawa A
    Prog Lipid Res; 1993; 32(4):417-34. PubMed ID: 8309950
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of a new thromboxane A2 receptor blocker in biological fluids by capillary gas chromatography with electron-capture detection.
    Uebis V
    J Chromatogr; 1987 Aug; 419():345-50. PubMed ID: 2959674
    [No Abstract]   [Full Text] [Related]  

  • 20. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
    Mais DE; Kochel PJ; Saussy DL; Halushka PV
    Mol Pharmacol; 1985 Aug; 28(2):163-9. PubMed ID: 2991736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.